Is there an interaction between amoxicillin (Amoxil) and warfarin?

Yes, there is a clinically significant interaction between amoxicillin (Amoxil) and warfarin that can increase bleeding risk.

When amoxicillin is prescribed to a patient on stable warfarin therapy, you must increase INR monitoring frequency to prevent potentially life-threatening bleeding complications. 1, 2

Mechanism of Interaction

The interaction occurs through two primary pathways:

• All antibiotics, including amoxicillin, alter the gut microbiome, which is a rich source of vitamin K, thereby potentiating warfarin's anticoagulant effects 1
• This vitamin K depletion mechanism applies universally to antibiotics, making INR elevation predictable when any antibiotic is initiated in warfarin-treated patients

Clinical Significance & Evidence

The dose of amoxicillin matters significantly. In a prospective study of 120 patients receiving amoxicillin/clavulanate with warfarin, 87.5% of patients on high-dose therapy (10-12 g/day) developed INR ≥ 4, compared to only 28.9% on standard doses (up to 3.6 g/day) 1, 3. This represents a dose-dependent interaction that substantially increases over-anticoagulation risk.

Case reports document severe consequences, including:

• INR elevation to 20.4 with life-threatening bleeding requiring fresh frozen plasma and vitamin K 4
• Persistent postoperative bleeding in dental patients 5
• Large rectus sheath hematomas requiring interventional radiology 6

Management Algorithm

When prescribing amoxicillin to warfarin patients:

1. Increase INR monitoring frequency - Check INR within 3-5 days of starting the antibiotic, then weekly during therapy 1

2. For high-dose amoxicillin/clavulanate (≥10 g/day):

   • Consider empiric warfarin dose reduction of 10-15%
   • Monitor INR every 2-3 days initially
   • Expect INR values ≥ 4 in the majority of patients 3

3. Continue monitoring after antibiotic completion - INR may remain elevated for several days after stopping the antibiotic due to persistent gut flora disruption 1

4. Educate patients to report any signs of bleeding immediately (bruising, blood in urine/stool, prolonged bleeding from cuts) 2

Important Caveats

• The FDA warfarin label specifically lists penicillins (including amoxicillin) as drugs that can increase PT/INR response 2
• Polypharmacy amplifies risk: Each additional potentially interacting drug increases the odds of INR ≥ 4 by 2.5-fold 3
• The interaction is less predictable than with CYP2C9 inhibitors (like sulfamethoxazole or metronidazole), which have more consistent pharmacokinetic mechanisms 1
• Unlike sulfamethoxazole (25% dose reduction) or metronidazole (33% dose reduction), there is no established pre-emptive warfarin dose reduction protocol for amoxicillin 1

Comparison to Other Antibiotics

While amoxicillin causes clinically significant interactions, it is generally less potent than:

• Sulfamethoxazole/trimethoprim (doubles bleeding risk, requires 25% warfarin dose reduction) 1
• Metronidazole (requires 33% warfarin dose reduction) 1
• Fluoroquinolones (significantly elevate INR and bleeding risk) 1
• Macrolides like clarithromycin/erythromycin (strong CYP3A4 inhibitors) 1

However, amoxicillin is more problematic than β-lactams without clavulanate when used at standard doses 7.

Bottom line: Never prescribe amoxicillin to a warfarin patient without arranging close INR monitoring within 3-5 days, especially if using high doses or combination therapy with clavulanate.